Search Grant Opportunities

Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)

ID: RFA-DA-25-057 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Stimulant Use Disorder still does not have FDA- approved treatments. Neuromodulation, such as, for example, transcranial magnetic stimulation (TMC) has been successfully used for more than 10 years in major depressive disorder (MDD) where patients have failed one antidepressant and since 2018 it has been used for obsessive-compulsive disorder (OCD). Another example is transcranial direct current stimulation (tDCS) which is currently being developed for a range of mental and neurological conditions, and some of them have direct relevance for StUD vulnerable phenotype (cognitive dysfunction, compulsive, and impulsive traits). Other neuromodulation technologies potentially can also be applied to StUD. As not everyone who takes drugs becomes addicted, and while the StUD population's extreme heterogeneity represents a barrier to effective treatment development, there is a treatment gap that needs to be filled, especially for the high-risk vulnerable phenotype with low executive function and difficulties with response regulation - anxious-impulsive traits. Developing neuromodulation combined with behavioral treatment modalities (CBT, mindfulness-based approaches) that will help to maintain use decrease and prevent relapse would have tremendous value as a treatment option. Randomized controlled trials are needed to develop the treatment algorithms and to select the most efficacious one.
Background
Stimulant Use Disorder (StUD) still does not have FDA-approved treatments. Neuromodulation, such as transcranial magnetic stimulation (TMC) and transcranial direct current stimulation (tDCS), has been successfully used for major depressive disorder and obsessive-compulsive disorder. The purpose of this grant is to support the development of neuromodulatory devices with behavioral treatment as a component for StUD, targeting patients with vulnerable phenotype including those with reported qualitatively high levels of impulsivity, compulsivity, and cognitive dysfunction.

Grant Details
The grant aims to develop safe and effective treatments for StUD by proposing a clinical trial of the combination of any NIBS that can include TMS, tDCS, Alternating Current Stimulation, LIFU, paired with behavioral treatment such as CBT, mindfulness, contingency management. The studies proposed should identify and validate known as well as new neuromodulation targets and provide a comprehensive rationale of the behavioral and neurobiological effects of stimulation of these targets selection and their constituent brain networks.
The grant also supports the investigation of the effect of the proposed combination approach of neuromodulation and behavioral treatment on the indices of efficacy in a larger well-powered study.

Eligibility Requirements
All organizations administering an eligible parent award may apply for a supplement under this NOFO. Eligible organizations include higher education institutions, nonprofits, for-profit organizations, local governments, state governments, federal government agencies, U.S. territories or possessions, independent school districts, public housing authorities/Indian housing authorities, native American tribal organizations (other than federally recognized tribal governments), faith-based or community-based organizations, regional organizations, foreign organizations.

Period of Performance
The project period is limited to 5 years with an earliest start date in November 2024 and an expiration date in November 2024.

Grant Value
NIDA intends to commit $2,000,000 in FY 2025 to fund three to five awards. Application budgets are limited to $500K per year for direct costs but need to reflect the actual needs of the proposed project.

Overview

Category of Funding
Education
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 6/27/24 the National Institutes of Health posted grant opportunity RFA-DA-25-057 for Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required). The grant will be issued under grant program 93.279 Drug Abuse and Addiction Research Programs.

Timing

Posted Date
June 27, 2024, 12:00 a.m. EDT
Closing Date
Nov. 27, 2024, 12:00 a.m. EST Past Due
Last Updated
June 27, 2024, 9:31 a.m. EDT
Version
1
Archive Date
Jan. 2, 2025

Eligibility

Eligible Applicants
Small businesses
State governments
Special district governments
Private institutions of higher education
Public housing authorities/Indian housing authorities
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-057.html

Documents

Posted documents for RFA-DA-25-057

Grant Awards

Grants awarded through RFA-DA-25-057

Incumbent or Similar Grants

Grants similar to RFA-DA-25-057

Similar Active Opportunities

Open grant opportunities similar to RFA-DA-25-057